Industrial observation group from U.S. Embassy in Korea visited MEDIPOST headquarters in Pangyo on August 13.

The observation group toured the MEDIPOST stem cell exhibition hall, cord blood storage and research facilities etc. and had discussion with MEDIPOST staffs.

Especially they showed big interest on overseas clinical trial status of stem cell medicines, and treatment case of disease using cord blood etc.

In this regard, the staff from MEDIPOST mentioned that “The visit was a direct opportunity to show the high technological level of domestic stem cell and cord blood industry”.

Meanwhile, the Economic Department of U.S. Embassy in Korea started tour of major domestic corporates to expand their understanding on the industrial site, since this month. In biological sector, MEDIPOST was the only destination.